Body mass index, diabetes, and triple-negative breast cancer prognosis (Q30458239)

21 June 2017

title

Body mass index, diabetes, and triple-negative breast cancer prognosis (English)

1 reference

triple-negative breast cancer

21 June 2017

0 references

1 reference

Feng Gao

3

0 references

author name string

Sarah Tait

1

1 reference

21 June 2017

Jose M Pacheco

2

1 reference

21 June 2017

Caroline Bumb

4

1 reference

21 June 2017

Matthew James Ellis

5

1 reference

21 June 2017

Cynthia X Ma

6

1 reference

21 June 2017

language of work or name

English

0 references

publication date

29 May 2014

1 reference

Breast Cancer Research and Treatment

21 June 2017

published in

1 reference

21 June 2017

volume

146

1 reference

21 June 2017

issue

1

1 reference

21 June 2017

page(s)

189-197

1 reference

Prevalence of childhood and adult obesity in the United States, 2011-2012

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Adult weight change and risk of postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Plasma adiponectin concentrations and risk of incident breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Molecular links between obesity and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Impact of body mass index on clinical outcomes in triple-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Does obesity have an effect on outcomes in triple-negative breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Treatment and outcomes in diabetic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3002-Y

10.1007/S10549-014-3002-Y

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

21 June 2017

1030256352

0 references

1 reference